JCA · market access
Evidence that access teams can file.
Joint Clinical Assessments and national HTA have their own clocks and their own evidence bar. We program the comparative analyses, ITC support and dossier tables that access teams should not have to rebuild from a CSR.
Who it's for
The brief we take.
Market access, HEOR and biometrics leads preparing EU JCA, NICE, NCPE or other HTA submissions.
Deliverables
What leaves the studio.
- Indirect treatment comparison programming support
- JCA-aligned evidence tables
- Systematic-review data extraction QC
- Economic-model input traces from clinical data
- Reproducible analysis logs for HTA questions
Tools & standards
The stack, without the logo wall.
Engagement
How you hire us.
- JCA evidence workstream
- National HTA response sprint
- Standing HEOR programming retainer
Anonymized: comparative-efficacy table package prepared in parallel with the CSR so market access did not wait on medical writing.
FAQ
Before the call.
Do you write the HTA dossier?
We program and QC the evidence. Dossier narrative stays with your access writers; we keep the numbers traceable.
Also in the studio
Statistical Programming
Submission-ready analysis datasets and TLFs, programmed once and QC'd twice.
Clinical Study Reporting
CSR sections, appendices and in-text tables written to the numbers — not around them.
Data Management
Clean, lockable clinical databases with CDASH-minded eCRFs and a query process that does not stall sites.
Tell us what is on the clock.
A scoping call is thirty minutes. Bring a protocol, a TLF list, or a model that needs hands.